Eterna Therapeutics Stock Technical Analysis
| ERNA Stock | USD 0.44 0.03 6.38% |
As of the 28th of November, Eterna Therapeutics shows the Standard Deviation of 6.38, variance of 40.73, and Mean Deviation of 4.72. Eterna Therapeutics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.
Eterna Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Eterna, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to EternaEterna |
Eterna Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Eterna Therapeutics Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Eterna Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Eterna Therapeutics Trend Analysis
Use this graph to draw trend lines for Eterna Therapeutics. You can use it to identify possible trend reversals for Eterna Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Eterna Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Eterna Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Eterna Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.01 , which may suggest that Eterna Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 7.08, which is the sum of squared deviations for the predicted Eterna Therapeutics price change compared to its average price change.About Eterna Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Eterna Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Eterna Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Eterna Therapeutics price pattern first instead of the macroeconomic environment surrounding Eterna Therapeutics. By analyzing Eterna Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Eterna Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Eterna Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2020 | 2023 | 2024 (projected) | Dividend Yield | 4.4E-5 | 0.001673 | 0.001803 | Price To Sales Ratio | 140.66 | 126.6 | 132.93 |
Eterna Therapeutics November 28, 2024 Technical Indicators
Most technical analysis of Eterna help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Eterna from various momentum indicators to cycle indicators. When you analyze Eterna charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.22) | |||
| Market Risk Adjusted Performance | (1.28) | |||
| Mean Deviation | 4.72 | |||
| Coefficient Of Variation | (335.58) | |||
| Standard Deviation | 6.38 | |||
| Variance | 40.73 | |||
| Information Ratio | (0.32) | |||
| Jensen Alpha | (2.08) | |||
| Total Risk Alpha | (2.87) | |||
| Treynor Ratio | (1.29) | |||
| Maximum Drawdown | 39.97 | |||
| Value At Risk | (12.96) | |||
| Potential Upside | 7.84 | |||
| Skewness | 0.5335 | |||
| Kurtosis | 2.49 |
Complementary Tools for Eterna Stock analysis
When running Eterna Therapeutics' price analysis, check to measure Eterna Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eterna Therapeutics is operating at the current time. Most of Eterna Therapeutics' value examination focuses on studying past and present price action to predict the probability of Eterna Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eterna Therapeutics' price. Additionally, you may evaluate how the addition of Eterna Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |